ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AGE AgeX Therapeutics Inc

11.10
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 11.10 10:00:00
Open Price Low Price High Price Close Price Previous Close
11.10 11.10
more quote information »

Recent News

Date Time Source Heading
23/3/202408:27GLOBEAgeX Therapeutics Reports Fourth Quarter and Annual 2023..
08/3/202408:49EDGAR2Form 425 - Prospectuses and communications, business..
08/3/202408:47EDGAR2Form 8-K - Current report
07/3/202423:47EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202408:01EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
07/2/202408:05EDGAR2Form 8-K - Current report
05/2/202423:19EDGAR2Form SC 13D/A - General statement of acquisition of..
20/1/202408:05EDGAR2Form 8-K - Current report
18/1/202408:19EDGAR2Form SC 13D/A - General statement of acquisition of..
17/1/202401:11EDGAR2Form S-4/A - Registration of securities, business..
12/1/202408:05EDGAR2Form 8-K - Current report
10/1/202408:16EDGAR2Form SC 13D/A - General statement of acquisition of..
06/1/202408:05EDGAR2Form 8-K - Current report
29/12/202308:02EDGAR2Form 8-K - Current report
19/12/202308:25EDGAR2Form 8-K - Current report
14/12/202309:11EDGAR2Form SC 13D/A - General statement of acquisition of..
09/12/202308:05EDGAR2Form 8-K - Current report
02/12/202308:05EDGAR2Form 8-K - Current report
18/11/202308:05EDGAR2Form 8-K - Current report
17/11/202308:01EDGAR2Form SC 13D/A - General statement of acquisition of..
16/11/202301:38EDGAR2Form DEF 14A - Other definitive proxy statements
15/11/202308:25EDGAR2Form 8-K - Current report
15/11/202308:05BWAgeX Therapeutics Reports Third Quarter 2023 Financial..
08/11/202308:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/11/202308:05EDGAR2Form DEF 14A - Other definitive proxy statements
07/11/202308:05EDGAR2Form 8-K - Current report
02/11/202307:28EDGAR2Form SC 13D/A - General statement of acquisition of..
07/10/202307:05EDGAR2Form 8-K - Current report
23/9/202306:05EDGAR2Form PRE 14A - Other preliminary proxy statements
16/9/202306:05EDGAR2Form 8-K - Current report
09/9/202306:05EDGAR2Form 8-K - Current report
31/8/202306:05EDGAR2Form 425 - Prospectuses and communications, business..
30/8/202321:20EDGAR2Form 8-K - Current report
30/8/202321:00BWSerina Therapeutics and AgeX Therapeutics Enter into Merger..
26/8/202306:05EDGAR2Form 8-K - Current report
25/8/202306:48EDGAR2Form SC 13D/A - General statement of acquisition of..
15/8/202306:25EDGAR2Form 8-K - Current report
15/8/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/8/202306:05BWAgeX Therapeutics Reports Second Quarter 2023 Financial..
05/8/202306:05EDGAR2Form 8-K - Current report
25/7/202308:28BWAgeX Therapeutics Closes $36,000,000 Debt Exchange for..
22/7/202307:32BWAgeX Therapeutics Announces $36,000,000 Debt Exchange for..
22/7/202307:29EDGAR2Form 8-K - Current report
08/7/202306:05EDGAR2Form 8-K - Current report
24/5/202306:05BWAgeX Therapeutics Announces Appeal of NYSE American..
13/5/202306:05BWAgeX Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock